인공 고관절 및 인공 슬관절 시장 규모, 점유율 및 동향 분석 보고서 : 시술 부위별, 용도별, 지역별 및 부문별 전망(2026-2033년)

The global artificial hip and knee joints market size was valued at USD 13.3 billion in 2025 and is projected to grow from USD 13.7 billion in 2026 to USD 16.7 billion by 2033, growing at a CAGR of 2.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 46.0% in 2025. Rising cases of orthopedic diseases, such as osteoarthritis and rheumatoid arthritis, are expected to boost market growth. According to the World Health Organization (WHO) report from July 2023, approximately 528 million people worldwide were living with osteoarthritis, with the knee being the most commonly affected joint, impacting an estimated 365 million individuals. As osteoarthritis remains a leading cause of pain, disability, and reduced mobility among older adults, the growing prevalence of knee and hip degeneration is expected to increase demand for artificial hip and knee replacement procedures globally.

Factors such as the rising prevalence of hip fractures and the growing geriatric population are expected to drive market growth over the forecast period. According to the National Hip Fracture Database (NHFD) Annual Report 2024, more than 70,000 hip fractures were recorded across England, Wales, and Northern Ireland in 2023, representing one of the highest annual totals reported in recent years. As hip fractures are strongly associated with aging populations, osteoporosis, and reduced mobility, the increasing burden of these injuries is expected to support the demand for hip replacement procedures and advanced orthopedic implants.

An article published by the American Orthopedic Foot & Ankle Society states that the most common sports injuries occur in the lower extremities, with children being more susceptible than young adults. This research presented findings from 27 U.S. high schools over three years, showing that the lowest-leg injuries occurred during soccer, indoor track races, and cross-country races. A significant surge in treatment adoption rates in developed & emerging countries and growing participation in sports are expected to fuel market growth during the forecast period, consequently driving the adoption of artificial hip & knee joints.

Furthermore, market participants are concentrating on bolstering R&D efforts to introduce advanced products and are focusing on various strategies to maintain their market position. For instance, in March 2025, Stryker launched the fourth-generation Mako SmartRobotics platform, featuring enhanced planning, workflow, and data-driven capabilities for hip and knee replacement procedures. The continued investment in robotic-assisted orthopedic technologies highlights the industry's focus on improving surgical precision, patient outcomes, and procedural efficiency, thereby supporting market growth.

Moreover, favorable government initiatives and reimbursement policies fuel the market growth. For example, Medicaid is a joint federal-state program in the U.S. that provides health insurance to eligible low-income individuals and families. Each state administers its Medicaid program; therefore, reimbursement policies for orthopedic joints and implants may vary by state. States often follow federal guidelines set by the Centers for Medicare & Medicaid Services. However, they may have their own rules and fee schedules for reimbursing orthopedic procedures.

Global Artificial Hip And Knee Joints Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country level and provides an analysis of industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global artificial hip and knee joints market report based on the site, end use, and region:

• Site Outlook (Revenue USD Billion, 2021 - 2033)

Hip Joints

• By Hip Product
  • Total Hip
  • Partial Femoral Head
  • Hip Resurfacing
  • Revision Hip

Knee Joints

• By Knee Product
  • Fixed-bearing Implants
  • Mobile-bearing Implants
• By Knee Procedure
  • Total Knee Replacement
  • Partial Knee Replacement
  • Revision Knee Replacement
• End Use Outlook (Revenue USD Billion, 2021 - 2033)

Hospitals & Surgery Centers

Orthopedic Clinics

Others

Regional Outlook (Revenue USD Billion, 2021 - 2033)

• North America

U.S.

Canada

Mexico

• Europe

Germany

UK

Spain

Italy

France

Denmark

Norway

Sweden

• Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

• Latin America

Brazil

Argentina

• MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Site outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Artificial Hip & Knee Joints Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Artificial hip & knee joints: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Framework
• 3.5. Product Pipeline Analysis

Chapter 4. Artificial Hip & Knee Joints Market Segment Analysis, By Site, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Site Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global artificial hip & knee joints market, by Site, 2021 to 2033
• 4.5. Hip Joints
  • 4.5.1. Hip Joints market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. Total Hip
    • 4.5.2.1. Total Hip market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.2.2. Partial Femoral Head
      • 4.5.2.2.1. Partial Femoral Head market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.2.3. Hip Resurfacing
      • 4.5.2.3.1. Hip Resurfacing market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.2.4. Revision Hip
      • 4.5.2.4.1. Revision Hip market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Knee Joints
  • 4.6.1. By Knee Products
  • 4.6.2. Fixed-bearing Implants
    • 4.6.2.1. Fixed-bearing Implants market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.3. Mobile-bearing Implants
    • 4.6.3.1. Mobile-bearing Implants market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.4. By Knee Procedure
  • 4.6.5. Total knee replacement
    • 4.6.5.1. Total knee replacement market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.6. Partial knee replacement
    • 4.6.6.1. Partial knee replacement market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.7. Revision knee replacement
    • 4.6.7.1. Revision knee replacement market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Artificial Hip & Knee Joints Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global artificial hip & knee joints market, by End Use, 2021 to 2033
• 5.5. Hospitals & Surgery Centers
  • 5.5.1. Hospitals & Surgery Centers market estimates and forecasts, 2021 to 2033 (USD million)
• 5.6. Orthopedic Clinics
  • 5.6.1. Orthopedic Clinics market estimates and forecasts, 2021 to 2033 (USD million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 6. Artificial Hip & Knee Joints Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Artificial Hip & Knee Joints Market Share by Region, 2025 & 2033:
• 6.5. North America
  • 6.5.1. North America artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. U.S. artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Canada artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Mexico artificial hip & knee joints market, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. UK artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Germany artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. France artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Italy artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Spain artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Norway artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Sweden artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Denmark artificial hip & knee joints market, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Japan artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. China artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. India artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Australia artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. South Korea artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Thailand artificial hip & knee joints market, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Brazil artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Argentina artificial hip & knee joints market, 2021 - 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. South Africa artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Saudi Arabia artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. UAE artificial hip & knee joints market, 2021 - 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Kuwait artificial hip & knee joints market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Profiles
  • 7.3.1. Exactech, Inc.
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. CORENTEC Co., Ltd.
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Smith+Nephew
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Zimmer Biomet
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Johnson & Johnson (DePuy Synthes)
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Enovis Corporation
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Medacta International
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. MicroPort Orthopedics, Inc.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Stryker
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. CONMED Corporation
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives